Picture EBD Group World of Partnering Opportunities 650x100px

Person › Details

Mary-Jane Elliott (Consilium Strategic Communications Ltd. (CSC))

Elliott, Mary-Jane (Consilium SC 201307– Managing Partner + Co-founder before M:Communications)

	Organisation	Consilium Strategic Communications Ltd. (CSC)
	Group	ICR (Group)
	Former/major organisation	M:Communications (division of King Worldwide)
	Group	King Worldwide (Group)
	Product	public relations / investor relations / marcom (services)
	Product 2	LIFE SCIENCES

Record changed: 2023-11-16

Picture Berlin Partner Special Topic HealthCapital Berlin-Brandenburg 650x200px

More documents for Mary-Jane Elliott

[1] ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY....
[2] MoonLake Immunotherapeutics AG. (6/28/23). "Press Release: MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares". Zug....
[3] MoonLake Immunotherapeutics AG. (6/26/23). "Press Release: MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering". Zug....
[4] Oxford Biomedica plc. (12/22/22). "Press Release: Oxford Biomedica to Present at 41st Annual J.P. Morgan Healthcare Conference". Seattle, WA....
[5] Consilium Strategic Communications Ltd.. (5/6/22). "Press Release: Consilium Strategic Communications Appoints Tracy Cheung as Partner". London....
[6] Silence Therapeutics plc. (10/15/21). "Press Release: Silence Therapeutics and Hansoh Pharma Announce Collaboration to Develop Therapeutics Leveraging Silence’s mRNAi GOLD™ Platform". London & Shanghai....
[7] Achilles Therapeutics plc. (4/6/21). "Press Release: Achilles Therapeutics Announces Closing of $175.5 Million Initial Public Offering". London....
[8] Achilles Therapeutics plc. (3/30/21). "Press Release: Achilles Therapeutics Announces Pricing of Initial Public Offering". London....
[9] Achilles Therapeutics plc. (3/1/21). "Press Release: Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States". London....
[10] Oxford BioMedica plc. (9/1/20). "Press Release: Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222". Oxford....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]